• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

钆塞酸二钠增强磁共振成像中肝细胞癌的包膜表现:与病理及动态CT的相关性

The capsule appearance of hepatocellular carcinoma in gadoxetic acid-enhanced MR imaging: Correlation with pathology and dynamic CT.

作者信息

Kim Bohyun, Lee Jei Hee, Kim Jai Keun, Kim Hye Jin, Kim Young Bae, Lee Dakeun

机构信息

Department of Radiology Department of Pathology, Ajou University School of Medicine, Suwon-si, Republic of Korea.

出版信息

Medicine (Baltimore). 2018 Jun;97(25):e11142. doi: 10.1097/MD.0000000000011142.

DOI:10.1097/MD.0000000000011142
PMID:29924016
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6023655/
Abstract

This study aimed to evaluate the capability of gadoxetic acid-enhanced MR (GAeMR) to detect presence of capsule appearance in hepatocellular carcinoma (HCC), and to correlate it with dynamic computed tomography (CT) and pathological features.Sixty-three patients (54: 9 = M: F, mean age 55.8) surgically confirmed HCCs with preoperative CT and GAeMR were included in this retrospective study. Two readers evaluated presence of capsule appearances on CT and GAeMR images in each phase including precontrast (Pre), portal phase (PP), delayed phase (DP), transitional phase (TP), and hepatobiliary phase (HBP). Histologic capsule was compared with CT and GAeMR. Diagnostic performance of CT and GAeMR of each phase for histologic capsule was evaluated and compared by receiver operating characteristic curve. Interobserver agreement was assessed with kappa statistics.Histologically the capsule was complete in 12.7% (8/63) and incomplete in 60.3% (38/63). Four cases (6.3%) were pseudocapsule. Interobserver agreement for capsule appearance on GAeMR was good in Pre (κ = 0.684), moderate in PP (κ = 0.434), poor in TP (κ = 0.187), fair in HBP (κ = 0.395), and moderate on CT in PP (κ = 0.476) and DP (κ = 0.485). Diagnostic performance and sensitivity for the histologic capsule in DP on CT was highest among PP on CT and other phases on GAeMR. DP on CT images showed a higher Az value than PP on CT images with statistical significance (P < .001). PP on MR images revealed higher Az value than PP on CT images.The capsule appearance was most frequently observed in the DP on CT with highest diagnostic performance, and so DP images should be obtained on CT study for liver mass categorization. GAeMR yielded comparable capsule appearance to CT with moderate interobserver agreement. Considering hypointense rim on the HBP as fibrous capsule on pathology should be refrained, and so further study is warranted to correlate HBP hypointense rim with pathologic findings.

摘要

本研究旨在评估钆塞酸二钠增强磁共振成像(GAeMR)检测肝细胞癌(HCC)包膜表现的能力,并将其与动态计算机断层扫描(CT)及病理特征相关联。本回顾性研究纳入了63例经手术证实的HCC患者(男∶女 = 54∶9,平均年龄55.8岁),这些患者术前均接受了CT和GAeMR检查。两名阅片者评估了每个时期(包括平扫期(Pre)、门静脉期(PP)、延迟期(DP)、移行期(TP)和肝胆期(HBP))CT和GAeMR图像上的包膜表现。将组织学包膜与CT和GAeMR结果进行比较。通过绘制受试者工作特征曲线评估并比较CT和各时期GAeMR对组织学包膜的诊断性能。采用kappa统计量评估观察者间的一致性。组织学检查显示,12.7%(8/63)的包膜完整,60.3%(38/63)的包膜不完整。4例(6.3%)为假包膜。GAeMR上包膜表现的观察者间一致性在平扫期良好(κ = 0.684),门静脉期中等(κ = 0.434),移行期较差(κ = 0.187),肝胆期一般(κ = 0.395);CT上门静脉期(κ = 0.476)和延迟期(κ = 0.485)的观察者间一致性中等。CT延迟期对组织学包膜的诊断性能和敏感性在CT门静脉期及GAeMR其他时期中最高。CT图像延迟期的Az值高于CT图像门静脉期,差异有统计学意义(P < 0.001)。MR图像门静脉期的Az值高于CT图像门静脉期。CT延迟期包膜表现最常见且诊断性能最高,因此肝脏肿块分类的CT检查应获取延迟期图像。GAeMR的包膜表现与CT相当,观察者间一致性中等。不应将肝胆期的低信号边缘视为病理上的纤维包膜,因此有必要进一步研究肝胆期低信号边缘与病理结果的相关性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8495/6023655/076e6f0a5a83/medi-97-e11142-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8495/6023655/6872391349ac/medi-97-e11142-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8495/6023655/076e6f0a5a83/medi-97-e11142-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8495/6023655/6872391349ac/medi-97-e11142-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8495/6023655/076e6f0a5a83/medi-97-e11142-g003.jpg

相似文献

1
The capsule appearance of hepatocellular carcinoma in gadoxetic acid-enhanced MR imaging: Correlation with pathology and dynamic CT.钆塞酸二钠增强磁共振成像中肝细胞癌的包膜表现:与病理及动态CT的相关性
Medicine (Baltimore). 2018 Jun;97(25):e11142. doi: 10.1097/MD.0000000000011142.
2
Diagnostic performance of gadoxetic acid-enhanced liver MR imaging in the detection of HCCs and allocation of transplant recipients on the basis of the Milan criteria and UNOS guidelines: correlation with histopathologic findings.钆塞酸增强肝脏磁共振成像在检测 HCC 和根据米兰标准和 UNOS 指南分配肝移植受者中的诊断性能:与组织病理学发现的相关性。
Radiology. 2015 Jan;274(1):149-60. doi: 10.1148/radiol.14140141. Epub 2014 Sep 5.
3
MR-imaging features of hepatocellular carcinoma capsule appearance in cirrhotic liver: comparison of gadoxetic acid and gadobenate dimeglumine.MRI 成像特征在肝硬化肝脏中的肝癌包膜表现:钆塞酸和钆贝葡胺的比较。
Abdom Radiol (NY). 2016 Aug;41(8):1546-54. doi: 10.1007/s00261-016-0726-7.
4
Small (≤1-cm) hepatocellular carcinoma: diagnostic performance and imaging features at gadoxetic acid-enhanced MR imaging.小肝癌(≤1cm):钆塞酸增强磁共振成像的诊断性能和影像学特征。
Radiology. 2014 Jun;271(3):748-60. doi: 10.1148/radiol.14131996. Epub 2014 Feb 1.
5
Added value of smooth hypointense rim in the hepatobiliary phase of gadoxetic acid-enhanced MRI in identifying tumour capsule and diagnosing hepatocellular carcinoma.钆塞酸二钠增强MRI肝胆期平滑低信号环在识别肿瘤包膜及诊断肝细胞癌中的附加价值
Eur Radiol. 2017 Jun;27(6):2610-2618. doi: 10.1007/s00330-016-4634-6. Epub 2016 Oct 21.
6
Intra-individual comparison of hepatocellular carcinoma imaging features on contrast-enhanced computed tomography, gadopentetate dimeglumine-enhanced MRI, and gadoxetic acid-enhanced MRI.肝细胞癌在对比增强计算机断层扫描、钆喷酸葡胺增强磁共振成像和钆塞酸二钠增强磁共振成像上的个体内影像特征比较
Acta Radiol. 2018 Jun;59(6):639-648. doi: 10.1177/0284185117728534. Epub 2017 Aug 20.
7
Gadoxetic acid-enhanced magnetic resonance imaging for differentiating small hepatocellular carcinomas (< or =2 cm in diameter) from arterial enhancing pseudolesions: special emphasis on hepatobiliary phase imaging.钆塞酸增强磁共振成像在鉴别 < 或 = 2cm 直径的小肝癌和动脉期增强假性病灶中的应用:特别强调肝胆期成像。
Invest Radiol. 2010 Feb;45(2):96-103. doi: 10.1097/RLI.0b013e3181c5faf7.
8
LI-RADS Version 2018 Targetoid Appearances on Gadoxetic Acid-Enhanced MRI: Interobserver Agreement and Diagnostic Performance for the Differentiation of HCC and Non-HCC Malignancy.LI-RADS 版本 2018 钆塞酸增强 MRI 上的靶样外观:鉴别 HCC 和非 HCC 恶性肿瘤的观察者间协议和诊断性能。
AJR Am J Roentgenol. 2022 Sep;219(3):421-432. doi: 10.2214/AJR.22.27380. Epub 2022 Mar 23.
9
LI-RADS v2014 categorization of hepatocellular carcinoma: Intraindividual comparison between gadopentetate dimeglumine-enhanced MRI and gadoxetic acid-enhanced MRI.LI-RADS v2014 肝细胞癌分类:钆喷酸葡胺增强 MRI 与钆塞酸二钠增强 MRI 的个体内比较。
Eur Radiol. 2019 Jan;29(1):401-410. doi: 10.1007/s00330-018-5559-z. Epub 2018 Jun 19.
10
Gadoxetic acid-enhanced MRI versus triple-phase MDCT for the preoperative detection of hepatocellular carcinoma.钆塞酸二钠增强磁共振成像与多期多层螺旋CT用于术前检测肝细胞癌的比较
AJR Am J Roentgenol. 2009 Jun;192(6):1675-81. doi: 10.2214/AJR.08.1262.

引用本文的文献

1
LI-RADS-based hepatocellular carcinoma risk mapping using contrast-enhanced MRI and self-configuring deep learning.基于肝脏影像报告和数据系统(LI-RADS)的肝细胞癌风险图谱绘制:使用对比增强磁共振成像和自配置深度学习技术
Cancer Imaging. 2025 Mar 17;25(1):36. doi: 10.1186/s40644-025-00844-6.
2
Re-assessing the diagnostic value of the enhancing capsule in hepatocellular carcinoma imaging.重新评估强化包膜在肝细胞癌成像中的诊断价值。
J Liver Cancer. 2024 Sep;24(2):206-216. doi: 10.17998/jlc.2024.05.01. Epub 2024 May 8.
3
An Imaging Feature Predicts Efficacy of Atezolizumab Plus Bevacizumab in Unresectable Hepatocellular Carcinoma.

本文引用的文献

1
2017 Version of LI-RADS for CT and MR Imaging: An Update.2017 版 CT 和 MR 成像肝脏影像学报告和数据系统:更新。
Radiographics. 2017 Nov-Dec;37(7):1994-2017. doi: 10.1148/rg.2017170098.
2
LI-RADS major features: CT, MRI with extracellular agents, and MRI with hepatobiliary agents.LI-RADS 主要特征:CT、MRI 联合细胞外对比剂和 MRI 联合肝胆对比剂。
Abdom Radiol (NY). 2018 Jan;43(1):75-81. doi: 10.1007/s00261-017-1291-4.
3
Intra-individual comparison of hepatocellular carcinoma imaging features on contrast-enhanced computed tomography, gadopentetate dimeglumine-enhanced MRI, and gadoxetic acid-enhanced MRI.
一种影像学特征可预测阿替利珠单抗联合贝伐单抗治疗不可切除肝细胞癌的疗效。
Cancer Diagn Progn. 2023 Jul 3;3(4):468-474. doi: 10.21873/cdp.10241. eCollection 2023 Jul-Aug.
4
Deep learning-assisted LI-RADS grading and distinguishing hepatocellular carcinoma (HCC) from non-HCC based on multiphase CT: a two-center study.深度学习辅助的 LI-RADS 分级和基于多期 CT 鉴别肝细胞癌(HCC)与非 HCC:一项双中心研究。
Eur Radiol. 2023 Dec;33(12):8879-8888. doi: 10.1007/s00330-023-09857-w. Epub 2023 Jul 1.
5
Prediction microvascular invasion of hepatocellular carcinoma based on tumour margin enhancing pattern in multiphase computed tomography images.基于多期计算机断层扫描图像中肿瘤边缘强化模式预测肝细胞癌微血管侵犯
Pol J Radiol. 2023 May 10;88:e238-e243. doi: 10.5114/pjr.2023.127578. eCollection 2023.
6
Mechanical Regulation of Mitochondrial Dynamics and Function in a 3D-Engineered Liver Tumor Microenvironment.三维工程化肝肿瘤微环境中,线粒体动力学和功能的机械调控。
ACS Biomater Sci Eng. 2023 May 8;9(5):2408-2425. doi: 10.1021/acsbiomaterials.2c01518. Epub 2023 Mar 31.
7
Imaging Diagnosis of Hepatocellular Carcinoma: A State-of-the-Art Review.肝细胞癌的影像学诊断:最新进展综述
Diagnostics (Basel). 2023 Feb 8;13(4):625. doi: 10.3390/diagnostics13040625.
8
Prospective evaluation of low-dose multiphase hepatic computed tomography for detecting and characterizing hepatocellular carcinoma in patients with chronic liver disease.前瞻性评估低剂量多期肝脏 CT 检测和诊断慢性肝病患者肝细胞癌的效能。
BMC Med Imaging. 2022 Dec 17;22(1):219. doi: 10.1186/s12880-022-00947-7.
9
State-of-the-art review on the correlations between pathological and magnetic resonance features of cirrhotic nodules.肝硬化结节的病理与磁共振特征相关性的最新研究进展综述。
Histol Histopathol. 2022 Dec;37(12):1151-1165. doi: 10.14670/HH-18-487. Epub 2022 Jun 30.
10
Computed tomography for the diagnosis of hepatocellular carcinoma in adults with chronic liver disease.计算机断层扫描在慢性肝病成人肝细胞癌诊断中的应用。
Cochrane Database Syst Rev. 2021 Oct 6;10(10):CD013362. doi: 10.1002/14651858.CD013362.pub2.
肝细胞癌在对比增强计算机断层扫描、钆喷酸葡胺增强磁共振成像和钆塞酸二钠增强磁共振成像上的个体内影像特征比较
Acta Radiol. 2018 Jun;59(6):639-648. doi: 10.1177/0284185117728534. Epub 2017 Aug 20.
4
Liver Imaging Reporting and Data System: Discordance Between Computed Tomography and Gadoxetate-Enhanced Magnetic Resonance Imaging for Detection of Hepatocellular Carcinoma Major Features.肝脏影像报告和数据系统:计算机断层扫描与钆塞酸二钠增强磁共振成像在检测肝细胞癌主要特征方面的不一致性
J Comput Assist Tomogr. 2018 Jan/Feb;42(1):155-161. doi: 10.1097/RCT.0000000000000642.
5
Change in Liver Imaging Reporting and Data System Characterization of Focal Liver Lesions Using Gadoxetate Disodium Magnetic Resonance Imaging Compared With Contrast-Enhanced Computed Tomography.与对比增强计算机断层扫描相比,使用钆塞酸二钠磁共振成像对肝脏局灶性病变进行肝脏影像报告和数据系统特征的变化
J Comput Assist Tomogr. 2017 May/Jun;41(3):376-381. doi: 10.1097/RCT.0000000000000536.
6
Added value of smooth hypointense rim in the hepatobiliary phase of gadoxetic acid-enhanced MRI in identifying tumour capsule and diagnosing hepatocellular carcinoma.钆塞酸二钠增强MRI肝胆期平滑低信号环在识别肿瘤包膜及诊断肝细胞癌中的附加价值
Eur Radiol. 2017 Jun;27(6):2610-2618. doi: 10.1007/s00330-016-4634-6. Epub 2016 Oct 21.
7
Liver imaging reporting and data system v2014 categorization of hepatocellular carcinoma on gadoxetic acid-enhanced MRI: Comparison with multiphasic multidetector computed tomography.肝脏影像报告和数据系统(LI-RADS)v2014对钆塞酸二钠增强MRI上肝细胞癌的分类:与多期多层螺旋CT的比较
J Magn Reson Imaging. 2017 Mar;45(3):731-740. doi: 10.1002/jmri.25406. Epub 2016 Jul 30.
8
Rate of observation and inter-observer agreement for LI-RADS major features at CT and MRI in 184 pathology proven hepatocellular carcinomas.在 184 例经病理证实的肝细胞癌中,CT 和 MRI 上 LI-RADS 主要特征的观察率和观察者间一致性。
Abdom Radiol (NY). 2016 May;41(5):963-9. doi: 10.1007/s00261-015-0623-5.
9
MR-imaging features of hepatocellular carcinoma capsule appearance in cirrhotic liver: comparison of gadoxetic acid and gadobenate dimeglumine.MRI 成像特征在肝硬化肝脏中的肝癌包膜表现:钆塞酸和钆贝葡胺的比较。
Abdom Radiol (NY). 2016 Aug;41(8):1546-54. doi: 10.1007/s00261-016-0726-7.
10
Liver Imaging Reporting and Data System:: Substantial Discordance Between CT and MR for Imaging Classification of Hepatic Nodules.肝脏影像报告和数据系统:CT与MR在肝结节影像分类上存在显著差异。
Acad Radiol. 2016 Mar;23(3):344-52. doi: 10.1016/j.acra.2015.11.002. Epub 2016 Jan 7.